Katherine Murray's most recent trade in Westwood Holdings Group Inc was a trade of 5,690 common stock done . Disclosure was reported to the exchange on April 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Westwood Holdings Group Inc | Katherine A. Murray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 5,690 | 5,690 (0%) | 0% | 0 | common stock | |
| Core Laboratories N.V. | Katherine A. Murray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 9,317 | 0 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Katherine A. Murray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 9,317 | 21,221 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Katherine A. Murray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 8,069 | 8,069 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Katherine Murray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 9,317 | 9,317 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Katherine Murray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 6,419 | 0 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Katherine Murray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 6,419 | 11,904 (0%) | 0% | 0 | Common Stock | |
| Core Laboratories N.V. | Katherine Murray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 6,419 | 6,419 | - | - | Restricted Shares | |
| Core Laboratories N.V. | Katherine Murray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 5,485 | 5,485 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories N.V. | Katherine Murray | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 5,485 | 0 | - | - | Restricted Shares |